COVID-19 Vaccine Makers Chase Variant-Ready Vaccines

0
34
Pfizer aims to have an Omicron-specific COVID-19 vaccine ready by March. Assuming it gains approval, it will mark the first revision of its mRNA vaccine Comirnaty since the initial Emergency Use Authorization of the vaccine by the FDA on 11 December 2020.
[Nature News]

Sorry, but the selected Zotpress account can't be found.

Press Release